Stocks and Investing Stocks and Investing
Wed, January 10, 2024
Tue, January 9, 2024
Mon, January 8, 2024

Serge Belanger Reiterated (BCRX) at Strong Buy and Held Target at $12 on, Jan 8th, 2024


Published on 2024-10-28 08:14:18 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Reiterated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $12 on, Jan 8th, 2024.

Serge has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 0 agree with Serge's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Serge


  • Jessica Fye of "JP Morgan" Initiated at Buy and Held Target at $10 on, Monday, November 20th, 2023
  • Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $10 on, Monday, September 25th, 2023